Te
Tessa Therapeutics
Singapore SGFounded 2013120 employees
Private CapbiotechPrivateOncology
Platform: Virus-spec T
Market Cap
N/A
All Drugs
4
Clinical Trials
7
Failed / Terminated
2
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| TES-1600 | TES-1600 | Phase 1/2 | 2 | VEGF | CKD | ||
| TES-326 | TES-326 | Approved | 1 | Tau | HNSCCMeso | ||
| Tezebrutinib | TES-1657 | Preclinical | 2 | HER2 | LGSAtopic Derm | ||
| Mirivorutinib | TES-7971 | Phase 2/3 | 2 | WRN | SLEET |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (6)